BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 17695213)

  • 1. [The N-of-1 trial: the ideal study design that is underused].
    Vandenbroucke JP
    Ned Tijdschr Tandheelkd; 2007 Jun; 114(6):260-2. PubMed ID: 17695213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The N-of-1 trial: the ideal study design that is underused].
    Vandenbroucke JP
    Ned Tijdschr Geneeskd; 2006 Dec; 150(51):2794-5. PubMed ID: 17216726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Controlled randomized clinical trials].
    Jaillon P
    Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimising the design of phase II oncology trials: the importance of randomisation.
    Ratain MJ; Sargent DJ
    Eur J Cancer; 2009 Jan; 45(2):275-80. PubMed ID: 19059773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomised controlled trials in orthopaedic surgery and traumatology: overview of parameters and pitfalls.
    Soucacos PN; Johnson EO; Babis G
    Injury; 2008 Jun; 39(6):636-42. PubMed ID: 18533154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can external and subjective information ever be used to reduce the size of randomised controlled trials?
    Tan SB; Wee J; Wong HB; Machin D
    Contemp Clin Trials; 2008 Mar; 29(2):211-9. PubMed ID: 17720629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinician as investigator: participating in clinical trials in the practice setting: Appendix 1: fundamentals of study design.
    Lader EW; Cannon CP; Ohman EM; Newby LK; Sulmasy DP; Barst RJ; Fair JM; Flather M; Freedman JE; Frye RL; Hand MM; Jesse RL; Van de Werf F; Costa F;
    Circulation; 2004 Jun; 109(21):e302-4. PubMed ID: 15173052
    [No Abstract]   [Full Text] [Related]  

  • 8. [Reading a clinical trial report].
    Bergmann JF; Chassany O
    Rev Prat; 2000 Apr; 50(8):838-45. PubMed ID: 10874860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sample sizes for clinical trials with normal data.
    Julious SA
    Stat Med; 2004 Jun; 23(12):1921-86. PubMed ID: 15195324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trials in surgery.
    Lilford R; Braunholtz D; Harris J; Gill T
    Br J Surg; 2004 Jan; 91(1):6-16. PubMed ID: 14716788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Should the single subject design be regarded as a valid alternative to the randomised controlled trial?
    Newcombe RG
    Postgrad Med J; 2005 Sep; 81(959):546-7. PubMed ID: 16143679
    [No Abstract]   [Full Text] [Related]  

  • 12. Pre-trial evaluation of the potential for unblinding in drug trials: a prototype example.
    Walter SD; Awasthi S; Jeyaseelan L
    Contemp Clin Trials; 2005 Aug; 26(4):459-68. PubMed ID: 16054578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficiency of the cross-over design: an empirical estimation.
    Garcia R; Benet M; Arnau C; Cobo E
    Stat Med; 2004 Dec; 23(24):3773-80. PubMed ID: 15580599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A practical limit to trials needed in one-person randomized controlled experiments.
    Alemi R; Alemi F
    Qual Manag Health Care; 2007; 16(2):130-4. PubMed ID: 17426611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design of randomized controlled trials.
    Stanley K
    Circulation; 2007 Mar; 115(9):1164-9. PubMed ID: 17339574
    [No Abstract]   [Full Text] [Related]  

  • 16. [Methodological and statistical aspects of equivalence and non inferiority trials].
    Elie C; De Rycke Y; Jais JP; Marion-Gallois R; Landais P
    Rev Epidemiol Sante Publique; 2008 Aug; 56(4):267-77. PubMed ID: 18703296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trial methodology and patient characteristics did not influence the size of placebo effects on pain.
    Kamper SJ; Machado LA; Herbert RD; Maher CG; McAuley JH
    J Clin Epidemiol; 2008 Mar; 61(3):256-60. PubMed ID: 18226748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Designing phase III or IV trials for vaccines: choosing between individual or cluster randomised trial designs.
    Vaucher P
    Vaccine; 2009 Mar; 27(13):1928-31. PubMed ID: 19368773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the validity of clinical trials.
    Akobeng AK
    J Pediatr Gastroenterol Nutr; 2008 Sep; 47(3):277-82. PubMed ID: 18728521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical appraisal. 5. Randomised controlled trials: questions for valid evidence.
    Nelson EA
    NT Learn Curve; 1999 Jul; 3(5):6-8. PubMed ID: 10795227
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.